Funding agencies: This study was supported by an EFNS fellowship to Dr. Chiara Criscuolo and by a research grant from the Internationaal Parkinson Fonds (The Netherlands) to Dr. Vincenzo Bonifati.
The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from Southern Italy†
Version of Record online: 29 APR 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 9, pages 1732–1736, 1 August 2011
How to Cite
Criscuolo, C., De Rosa, A., Guacci, A., Simons, E. J., Breedveld, G. J., Peluso, S., Volpe, G., Filla, A., Oostra, B. A., Bonifati, V. and De Michele, G. (2011), The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from Southern Italy. Mov. Disord., 26: 1732–1736. doi: 10.1002/mds.23735
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 9 AUG 2011
- Version of Record online: 29 APR 2011
- Manuscript Accepted: 24 FEB 2011
- Manuscript Revised: 22 FEB 2011
- Manuscript Received: 11 DEC 2010
Additional Supporting Information may be found in the online version of this article.
|MDS_23735_sm_suppinfo.tif||18273K||Supporting Information Figure|
|MDS_23735_sm_suppinfotab.doc||48K||Supporting Information Table 1. Clinical comparison between R1441C carriers and matched non-carriers PD patients.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.